Tag: foundation model
-
METR updates – METR: Common Elements of Frontier AI Safety Policies
Source URL: https://metr.org/blog/2025-03-26-common-elements-of-frontier-ai-safety-policies/ Source: METR updates – METR Title: Common Elements of Frontier AI Safety Policies Feedly Summary: AI Summary and Description: Yes Summary: The text discusses commitments by major developers of large foundation AI models to corporate protocols that focus on evaluating and mitigating severe risks associated with AI technologies. These protocols emphasize information…
-
Cloud Blog: Anyscale powers AI compute for any workload using Google Compute Engine
Source URL: https://cloud.google.com/blog/products/ai-machine-learning/anyscale-powers-ai-compute-for-any-workload-using-google-compute-engine/ Source: Cloud Blog Title: Anyscale powers AI compute for any workload using Google Compute Engine Feedly Summary: Over the past decade, AI has evolved at a breakneck pace, turning from a futuristic dream into a tool now accessible to everyone. One of the technologies that opened up this new era of AI…
-
Slashdot: Nvidia Says ‘the Age of Generalist Robotics Is Here’
Source URL: https://hardware.slashdot.org/story/25/03/18/2312229/nvidia-says-the-age-of-generalist-robotics-is-here?utm_source=rss1.0mainlinkanon&utm_medium=feed Source: Slashdot Title: Nvidia Says ‘the Age of Generalist Robotics Is Here’ Feedly Summary: AI Summary and Description: Yes Summary: Nvidia announced the Isaac GR00T N1, an open-source, customizable foundation model aimed at revolutionizing humanoid robotics. The model features a dual-system architecture that enhances robot learning and behavior, facilitating more advanced robot…
-
Cloud Blog: Accelerating AI in healthcare using NVIDIA BioNeMo Framework and Blueprints on GKE
Source URL: https://cloud.google.com/blog/products/ai-machine-learning/accelerate-ai-in-healthcare-nvidia-bionemo-gke/ Source: Cloud Blog Title: Accelerating AI in healthcare using NVIDIA BioNeMo Framework and Blueprints on GKE Feedly Summary: The quest to develop new medical treatments has historically been a slow, arduous process, screening billions of molecular compounds across decade-long development cycles. The vast majority of therapeutic candidates do not even make it…